ICD-10 Code C88.3 | Immunoproliferative small intestinal disease Symptoms, Diagnosis, Billing

Immunoproliferative small intestinal disease is a rare condition characterized by the abnormal proliferation of immune cells in the small intestine, often leading to malabsorption and gastrointestinal symptoms. It is clinically significant due to its potential complications, including intestinal lymphoma. The ICD-10 Code C88.3 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code C88.3 for Immunoproliferative small intestinal disease?

ICD-10 Code C88.3 represents Immunoproliferative small intestinal disease, a condition associated with the proliferation of lymphoid tissue in the small intestine. This code should be used when documenting cases of this disease, which may present with symptoms such as diarrhea, weight loss, and abdominal pain. Accurate coding is essential for appropriate clinical documentation and billing, as well as for tracking disease prevalence and outcomes.

ICD-10 Code C88.3 – Clinical Definition and Explanation of Immunoproliferative small intestinal disease

Immunoproliferative small intestinal disease is primarily caused by an abnormal immune response, often linked to chronic infections or autoimmune conditions. The disease can progress to severe malabsorption and may require urgent medical intervention. Early diagnosis and treatment are crucial to prevent complications such as intestinal obstruction or malignancy.

Key Clinical Features:

• Chronic diarrhea and weight loss
• Abdominal pain and bloating
• Nutritional deficiencies due to malabsorption
• Potential progression to intestinal lymphoma

ICD-10 Code C88.3 for Immunoproliferative small intestinal disease – SOAP Notes & Clinical Use

ICD-10 Code C88.3 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management strategies.

What Does ICD-10 Code C88.3 for Immunoproliferative small intestinal disease Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C88.3 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Immunoproliferative small intestinal disease. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C88.3 – Immunoproliferative small intestinal disease

Immunoproliferative small intestinal disease often necessitates hospitalization due to the risk of severe complications. Treatment may include specific therapies aimed at managing symptoms and addressing the underlying causes.

Antibiotic Therapy:

• First-line: Tetracycline or Metronidazole for 10-14 days
• Alternative: Ciprofloxacin for 7-14 days
• Consideration of antifungal agents if indicated

Supportive Care:

• Nutritional support with enteral feeding if necessary
• Management of electrolyte imbalances
• Symptomatic relief with antidiarrheal medications

Infection Control:

• Strict hand hygiene practices
• Isolation precautions if infectious etiology is suspected
• Monitoring for outbreaks in healthcare settings

How to Document Symptoms of Immunoproliferative small intestinal disease (ICD-10 C88.3) in SOAP Notes

Subjective:

• Patient reports chronic diarrhea lasting several weeks
• History of unintentional weight loss of 10 pounds
• Complaints of abdominal pain after meals
• Increased fatigue and weakness noted by the patient

Objective:

• Vital signs: BP 110/70, HR 88, Temp 98.6°F
• Abdominal examination reveals tenderness in the epigastric region
• Laboratory results show low serum albumin and electrolyte imbalances
• Stool analysis indicates malabsorption

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Immunoproliferative small intestinal disease (ICD-10 Code C88.3)

Assessment:

• Diagnosis: Immunoproliferative small intestinal disease, moderate severity
• ICD-10 Code: C88.3
• Contributing factors: Possible chronic infection or autoimmune disorder
• Consideration of differential diagnoses including lymphoma

Plan:

• Initiate antibiotic therapy as per guidelines
• Refer to nutritionist for dietary management
• Monitor electrolytes and provide IV fluids as needed
• Schedule follow-up in one week to reassess symptoms and treatment efficacy

Treatment & Plan Section for ICD-10 Code C88.3 – Immunoproliferative small intestinal disease

• First-line pharmacologic treatments include antibiotics and nutritional support.
• Non-pharmacologic strategies involve dietary modifications and symptom management.
• Monitoring practices include regular assessment of weight and nutritional status.
• Follow-up appointments should be scheduled to evaluate treatment response and adjust care plans.

Using ICD-10 Code C88.3 for Immunoproliferative small intestinal disease in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings and documentation.
• Ensure Subjective (S) and Objective (O) sections reflect the patient's symptoms and clinical status.
• Align treatment plans with clinical guidelines to support justified billing.
• Document any relevant CPT codes that correspond with the services provided.

Related ICD-10 Codes Often Used with Immunoproliferative small intestinal disease

ICD-10 Code C88.3 in Medical Billing and Insurance for Immunoproliferative small intestinal disease

ICD-10 Code C88.3 is critical for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.

Billing Notes:

• Document all relevant clinical findings to support the use of C88.3.
• Use this code in conjunction with other relevant codes for comprehensive billing.
• Ensure that all chart elements, including treatment plans, are clearly outlined.
• Review payer-specific guidelines for any additional documentation requirements.

Common CPT Pairings: